干预时机对肺栓塞导管定向治疗的影响
该回顾性队列研究纳入2014年1月至2021年10月单中心肺栓塞反应团队启动的64例患者,按入院至导管定向治疗时间分为早期(<24小时,39例,63.8%)和晚期(>24小时,25例,36.2%)两组。早期组入院至治疗时间15.9小时(9.1-20.3小时)vs 晚期组33.4小时(27.9-41小时)(p≤0.001)。早期组干预后肺动脉收缩压下降幅度更大(14 mm Hg [6-20 mm Hg] vs 6 mm Hg [1-10 mm Hg];p=0.022),住院时间更短(4天 vs 7天;p=0.038),ICU停留时间更短(3天 vs 5天;p=0.004),院内死亡率无差异(17.9% vs 12%;p=0.523)。作者认为两组住院时间差异幅度不能完全由导管定向治疗时间差异解释,早期治疗患者肺动脉血流动力学有适度改善。
要点
- 中危肺栓塞患者入院24小时内行导管定向治疗与更短住院时间相关(4天 vs 7天;p=0.038)。
- 早期导管定向治疗组ICU停留时间更短(3天 vs 5天;p=0.004)。
- 早期组干预后肺动脉收缩压下降幅度更大(14 mm Hg [6-20 mm Hg] vs 6 mm Hg [1-10 mm Hg];p=0.022)。
- 两组院内死亡率无差异(17.9% vs 12%;p=0.523)。
- 作者认为住院时间差异幅度不能完全由导管定向治疗时间差异解释。
适用人群与场景
- 2014年1月至2021年10月单中心肺栓塞反应团队启动的患者,共64例纳入分析。
研究设计与关键结果
- 回顾性队列研究,单中心,纳入64例肺栓塞反应团队启动的患者,按入院至导管定向治疗时间分为早期(<24小时,39例,63.8%)和晚期(>24小时,25例,36.2%)两组。
- 入院至导管定向治疗时间:早期组15.9小时(9.1-20.3小时)vs 晚期组33.4小时(27.9-41小时)(p≤0.001)。
- 干预后肺动脉收缩压下降幅度:早期组14 mm Hg(6-20 mm Hg)vs 晚期组6 mm Hg(1-10 mm Hg)(p=0.022)。
- 住院时间:早期组4天 vs 晚期组7天(p=0.038);ICU停留时间:早期组3天 vs 晚期组5天(p=0.004)。
- 院内死亡率:早期组17.9% vs 晚期组12%(p=0.523),无差异。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,入院24小时内行导管定向治疗的患者住院时间和ICU停留时间更短;两组住院时间差异幅度不能完全由导管定向治疗时间差异解释;早期治疗患者肺动脉血流动力学有适度改善。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Cather-directed therapies (CDTs) are an evolving therapeutic option for patients with intermediate-risk pulmonary embolism (PE). Although many techniques have been studied, there is limited evidence for the impact of timing of intervention on patient outcomes. Our objective was to assess the association between time to CDT in patients presenting with PE on patient-related outcomes such as length of stay (LOS) and mortality.
DESIGN: Retrospective cohort study.
SETTING: Single academic center.
PATIENTS: We identified patients for which the PE response team had been activated from January 2014 to October 2021. Patients were split into two cohorts depending on whether they went to CDT less than 24 hours from admission (early) versus greater than 24 hours (late).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Data on demographics, timing of interventions, pulmonary hemodynamics, and outcomes were collected. Sixty-four patients were included in analysis. Thirty-nine (63.8%) underwent their procedure less than 24 hours from admission, whereas 25 (36.2%) underwent the procedure after 24 hours. The time from admission to CDT was 15.9 hours (9.1-20.3 hr) in the early group versus 33.4 (27.9-41) in the late group (p ≤ 0.001). There was a greater decrease in pulmonary artery systolic pressure after intervention in the early cohort (14 mm Hg [6-20 mm Hg] vs 6 mm Hg [1-10 mm Hg]; p = 0.022). Patients who received earlier intervention were found to have shorter hospital LOS (4 vs 7 d; p = 0.038) and ICU LOS (3 vs 5 d; p = 0.004). There was no difference in inhospital mortality between the groups (17.9% vs 12%; p = 0.523).
CONCLUSIONS: Patients who underwent CDT within 24 hours of admission were more likely to have shorter hospital and ICU LOS. The magnitude of change in LOS between the two cohorts was not fully explained by the difference in time to CDT. There were modest improvements in pulmonary hemodynamics in the patients who underwent CDT earlier.
参考来源
- Lehr A, Guichet P, Garimella B, et al. Impact of Time to Intervention on Catheter-Directed Therapy for Pulmonary Embolism. Crit Care Explor. 2023. PMID: 36699257. doi:10.1097/CCE.0000000000000828
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。